Apollo Medical Inc.

AMEH | NASDAQ

Price Alert Chart Builder DCF Calculator

$40.82

-$0.88 (-2.11%)

Feb 23, 2024, 04:00 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $1.83B

Enterprise Value $2.41B

Beta 1.04

Average Volume N/A

Shares Outstanding (Diluted) 49.42M

Shares Change YoY 3.99%

Institutional Ownership N/A

Exchange N/A

ISIN N/A

Price Performance

Price Change 1M N/A

Price Change 3M N/A

Price Change 6M N/A

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) 8.4%

1Y CAGR (ann.) 23.1%

5Y CAGR (ann.) 16.0%

All-Time CAGR 22.4%

Valuation

PE Ratio 51.67

Forward PE N/A

PEG Ratio 1.19

Forward PEG 0.97

PS Ratio 0.41

Forward PS N/A

PB Ratio 2.20

P/FCF Ratio 18.78

P/Adj. FCF Ratio 32.29

P/OCF Ratio 18.55

EV/Sales 0.54

EV/EBIT 45.65

EV/EBITDA 18.60

EV/FCF 24.72

Earnings Yield 1.9%

FCF Yield 5.3%

Adj. FCF Yield 3.1%

Financial Health

Net Debt $535.71M

Total Debt $979.41M

Cash & Short-Term Investments $400.79M

Total Assets $2.28B

Current Ratio 1.23

Quick Ratio 1.23

Debt / Equity Ratio 1.18

Debt / EBITDA 7.56

Debt / FCF 10.05

OCF / Debt 0.11

Interest Coverage -47.93

Altman Z-Score 3.00

Piotroski F-Score 5

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 2.7%

EBITDA Margin 2.9%

Net Profit Margin 0.9%

FCF Margin 2.2%

Adj. FCF Margin 1.3%

SBC / Revenue 0.9%

SBC Impact (per share) -41.8%

Returns

Return on Assets 1.7%

Return on Equity 4.9%

Return on Invested Capital 4.9%

Return on Capital Employed 7.9%

Return on Tangible Assets 3.4%

Historical Growth (CAGR)

Revenue CAGR 3Y 54.6%

Revenue CAGR 5Y 45.2%

Revenue CAGR 10Y 59.6%

EPS CAGR 3Y -6.9%

EPS CAGR 5Y -8.2%

EPS CAGR 10Y 55.1%

FCF CAGR 3Y 28.9%

FCF CAGR 5Y 8.6%

FCF CAGR 10Y 24.7%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 3

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Aug 6, 2025

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number $14.74

Graham Upside -63.9%

Lynch Fair Value $3.95

Lynch Upside -90.3%

Price Target $48.50

Price Target Upside 18.8%

Cash Flow

Operating Cash Flow $107.87M

Free Cash Flow $97.45M

Adj. Free Cash Flow $56.69M

FCF Per Share $1.99

OCF Per Share $2.20

OCF/S Ratio 2.4%

Income Statement

Revenue $4.5B

Gross Profit $0

Operating Income $120.79M

EBITDA $129.53M

Net Income $39.26M

EPS (Diluted) $0.79

Revenue / Employee N/A

Profit / Employee N/A

Employees N/A